Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Exome Sequencing with nimblegen SeqCap EZ v3

    Hi,

    we working with a GAllx from Illumina and have good experience with nimblegen SeqCap EZ v2 (on target).
    We compare the nimblegen SeqCap EZ v3 and Illumina TrueSeq exome kits and the results shocked me .
    For nimblegen we have nice mapping rate and low duplication level, but on target it is only 30 %.
    For illumina mapping is well but duplicate level is high (20 - 30 %). On target we can reach 76 %.

    How it could be that the on target of nimblen v3 kit is so bad? We have good results in the pre steps and everything looks similar to nimblegen v2.

    About hints or sharing experience about the nimblegen v3 kit I would be very lucky.

  • #2
    What do you call on target?

    Comment


    • #3
      Hi,

      there are design files (.bed) with region information. And that reads mapped to the genome, including a region from the design file too, are on target.

      Comment


      • #4
        I know but some people take +- 100 or 200 bases as on target and some don't. Anyway 30% is very low, should be more towards >95% bases covered. We also used V3 and had +- 98%. Illumina performs slightly less with +- 92%.
        How deep did you sequence?

        Comment


        • #5
          Hi,

          we used this desing file "SeqCap_EZ_Exome_v3_capture.bed" it include +- 100bp.
          how deep means how many reads we get out or how many mapped?

          Comment


          • #6
            Hi,

            what you mentioned that 95% of bases are called means the uniformity.
            But the issue is that we mapped >90% of 100 000 000 reads to the genome and then we calculate the 30% on target amount (after duplication removement).

            Comment

            Latest Articles

            Collapse

            • seqadmin
              Current Approaches to Protein Sequencing
              by seqadmin


              Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
              04-04-2024, 04:25 PM
            • seqadmin
              Strategies for Sequencing Challenging Samples
              by seqadmin


              Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...
              03-22-2024, 06:39 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by seqadmin, 04-11-2024, 12:08 PM
            0 responses
            17 views
            0 likes
            Last Post seqadmin  
            Started by seqadmin, 04-10-2024, 10:19 PM
            0 responses
            22 views
            0 likes
            Last Post seqadmin  
            Started by seqadmin, 04-10-2024, 09:21 AM
            0 responses
            16 views
            0 likes
            Last Post seqadmin  
            Started by seqadmin, 04-04-2024, 09:00 AM
            0 responses
            46 views
            0 likes
            Last Post seqadmin  
            Working...
            X